The holding company operating in Hong Kong on Friday said it is issuing 1.375 million Class A ordinary shares at an estimated price between $4 and $5 per share. Following the offering, 9.2% of the ...
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
FORT LAUDERDALE, Fla. , Feb. 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- FAVO Capital, Inc. (OTC: FAVO), a private credit firm providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback